A genetically engineered E. coli probiotic producing sulforaphane reduced colorectal tumor size by over 75% in mice.

“Scientists use a probiotic and broccoli extract to target colorectal cancer cells. Probiotic was engineered to make an enzyme able to produce sulforaphane from the precursor in broccoli extract. It reduced tumor size by over 75% (in mice).”